WebAug 6, 2024 · In 2016, a CMA investigation found that Pfizer and its UK partner Flynn Pharma, broke competition law by charging “unfairly high” prices for phenytoin, which is used by an estimated 48,000 epilepsy patients in the UK to prevent and control seizures. WebJun 8, 2024 · 8th June 2024. by. Selina McKee. The Competition Appeal Tribunal in the UK has overturned a £90 million fine against Pfizer and Flynn Pharma issued by the Competition and Markets Authority for charging unfair prices for phenytoin sodium capsules. Originally Pfizer manufactured and sold the capsules to UK wholesalers and pharmacies …
CMA v Flynn Pharma and Pfizer: - Oxford Academic
WebFeb 7, 2024 · 1275/1/12/17 Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd v Competition and Markets Authority Registered 07/02/2024 Tribunal Peter Freeman CBE QC (Hon) Paul Lomas Professor Michael Waterson Status Summary of appeal published on 14 February 2024. A first case management conference (“CMC”) took place on 8 March … WebMay 8, 2014 · Unlike some pharmacies, Flynn's Pharmacy is accredited by the Accreditation Commission for Health Care. We are open 7 days a week, provide free … sidas 3feet activ
UK watchdog fines Pfizer, Flynn Pharma $84 mln for ... - Reuters
WebAug 16, 2024 · August 16, 2024. Press Release – CMA Phenytoin Investigation. Flynn Pharma is pleased to receive the judgment of the Court of Appeal regarding the CMA’s phenytoin investigation. This case is approaching its seventh anniversary, notwithstanding that Flynn had clearly set out its position and logic from the earliest days of the case. WebJul 21, 2024 · Summary. July 21 (Reuters) - Pfizer (PFE.N) and Flynn Pharma were fined a total of 70 million pounds ($84 million) on Thursday by Britain's antitrust watchdog for overcharging the National Health ... WebJun 7, 2024 · Pfizer and Flynn were each found to have infringed the Chapter II prohibition under the Competition Act 1998 (“CA 98”) and Article 102 of the Treaty on the … sidarth sl